KAREN NESCI: Open Payments
NPI 1881247799 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 81 payments from 16 companies in 2025. Trend: 2023 $1,814 · 2024 $2,317 · 2025 $1,877
Food & beverage: $1,768Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $569 |
| Janssen Biotech, Inc. | 12 | $331 |
| Madrigal Pharmaceuticals | 3 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $195 |
| Aimmune Therapeutics, Inc. | 4 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Gilead Sciences, Inc. | 3 | $61 |
| Intercept Pharmaceuticals, Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $46 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, ENTYVIO, VOWST, XIFAXAN, SKYRIZI, DUPIXENT.
Industry payments across NY — which companies pay providers there.
